AEMD vs PFE · $2.5M cap vs P/E 20, rev $62.58B
Aethlon Medical Inc (AEMD) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Aethlon Medical Inc (AEMD) is a medical devices company listed on US.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported AEMD revenue for 2024-03-31 was $0. Net income was -$12.2M. Revenue was down 100.0% from 2023-03-31 to 2024-03-31. AEMD currently screens at market cap $2.5M.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
AEMD currently screens at market cap $2.5M. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the AEMD and PFE stock pages for the full models.
Not investment advice.